METTL3-mediated m 6 A modification of DNMT1 enhances ovarian cancer progression
Science Advances · 06.11.2026 · 12 (45)
DOI: 10.1126/sciadv.aec2297 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 06.11.2026. Verfasst von Kanchan Kumari und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, Umeå University, SE-901 85 Umeå, Sweden. Hauptthemen laut MEDLINE: Ovarian Neoplasms, DNA (Cytosine-5-)-Methyltransferase 1, Methyltransferases, Adenosine. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Swedish Research Council Formas, Kempe Foundation, Cancerfonden.
Abstract (Originalsprache)
High-grade serous ovarian carcinoma (HGSOC), the most lethal subtype of ovarian cancer, is often diagnosed at advanced stages and remains associated with poor clinical outcome. In this study, we identify a critical oncogenic role of the RNA methyltransferase METTL3 and the N 6 -methyladenosine (m 6 A) RNA modification pathway in HGSOC. Suppression of METTL3, either genetically or pharmacologically, and depletion of its binding partner METTL14 impair ovarian cancer proliferation and tumor progression. Mechanistically, we show that METTL3-mediated m 6 A deposition enhances the translation of DNA methyltransferase 1 (DNMT1), the primary maintenance DNA methyltransferase responsible for preserving genome-wide methylation patterns and silencing tumor suppressor genes. Pharmacological inhibition of DNMT1 induces widespread DNA hypomethylation and up-regulation of the tumor suppressors TNFAIP3 and FBXO32. Consistently, METTL3 suppression reduces DNMT1 abundance and derepresses TNFAIP3 and FBXO32 expression. Knockdown and rescue studies further reveal that DNMT1 primarily mediates METTL3-dependent regulation of cell migration, whereas the antiproliferative effects of METTL3 suppression are likely driven by additional downstream targets. Collectively, these findings identify the m 6 A-METTL3-DNMT1 axis as a mechanistic link between RNA and DNA methylation pathways and a potential therapeutic vulnerability in HGSOC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology, Umeå University, SE-901 85 Umeå, Sweden.
- Wallenberg Centre for Molecular Medicine, Umeå University, SE-901 85 Umeå, Sweden.
- Cancer Research Program, Hospital del Mar Medical Research Institute (HMRI), Barcelona, Spain.
- Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Catalonia, Spain.
- Department of Biosciences, Faculty of Science, Technology and Engineering, University of Vic-Central University of Catalonia (UVic-UCC), Vic, Barcelona, Catalonia, Spain.
- Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Madrid, Spain.
ORCID-Profile: Kanchan Kumari, Iván Pérez-Núñez, Aleix Noguera Castells, Raquel Pluvinet, Carlos Peula, Erik Dassi, Chuan He, Eva Lundin, Manel Esteller, Toni Celià-Terrassa, Francesca Aguilo
Förderung
- Swedish Research Council Formas
- Kempe Foundation
- Cancerfonden
- Fundación Científica Asociación Española Contra el Cáncer
- Cancer Research Foundation in Northern Sweden
- Knut and Alice Wallenberg foundation
- Umeå University
- Västerbotten County Council
Zitieren
APA
Kumari, K., Pérez-Núñez, I., Noguera Castells, A., Pluvinet, R., Peula, C., Patthey, A., Khan, G. N., Pajdzik, K., Román, Á. C., Dassi, E., He, C., Lundin, E., Esteller, M., Celià-Terrassa, T., & Aguilo, F. (2026). METTL3-mediated m 6 A modification of DNMT1 enhances ovarian cancer progression. Science Advances, 12(45). https://doi.org/10.1126/sciadv.aec2297
Vancouver
Kumari K, Pérez-Núñez I, Noguera Castells A, Pluvinet R, Peula C, Patthey A, et al. METTL3-mediated m 6 A modification of DNMT1 enhances ovarian cancer progression. Science Advances. 2026;12(45). doi:10.1126/sciadv.aec2297
BibTeX
@article{Kumari2026,
author = {Kumari, Kanchan and Pérez-Núñez, Iván and Noguera Castells, Aleix and Pluvinet, Raquel and Peula, Carlos and Patthey, Annika and Khan, Ghazala Naz and Pajdzik, Kinga and Román, Ángel-Carlos and Dassi, Erik and He, Chuan and Lundin, Eva and Esteller, Manel and Celià-Terrassa, Toni and Aguilo, Francesca},
title = {METTL3-mediated m 6 A modification of DNMT1 enhances ovarian cancer progression},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {45},
doi = {10.1126/sciadv.aec2297}
}
EUVIMED